178

Immunology & Rheumatology
Focuses on rheumatic and immune diseases.
Sub Categories on Immunology & Rheumatology
Latest Articles
Antibodies against phosphorylcholine give protection against rheumatic systemic disease

Antibodies against phosphorylcholine give protection against rheumatic systemic disease

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainA novel study from the Institute of Environmental Medicine at Karolinska Institutet indicates that antibodies against a small lipid entity

Antibodies against phosphorylcholine give protection against rheumatic systemic disease

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainA novel study from the Institute of Environmental Medicine at Karolinska Institutet indicates that antibodies against a small lipid entity
mRNA-1273 induces stronger response than BNT162b2 for immunosuppressed

mRNA-1273 induces stronger response than BNT162b2 for immunosuppressed

For immunosuppressed patients, mRNA-1273 induces a stronger seroresponse than BNT162b2, according to a research letter published online May 16 inJAMA Network Open.Jonathan Mitchell, M.B.B.S., fr

mRNA-1273 induces stronger response than BNT162b2 for immunosuppressed

For immunosuppressed patients, mRNA-1273 induces a stronger seroresponse than BNT162b2, according to a research letter published online May 16 inJAMA Network Open.Jonathan Mitchell, M.B.B.S., fr
Surprise rheumatoid arthritis discovery points to new treatment for joint inflammation

Surprise rheumatoid arthritis discovery points to new treatment for joint inflammation

by University of VirginiaCredit: Alexandra Angelich, University CommunicationsResearchers at the University of Virginia School of Medicine have identified an unexpected contributor to rheumatoid

Surprise rheumatoid arthritis discovery points to new treatment for joint inflammation

by University of VirginiaCredit: Alexandra Angelich, University CommunicationsResearchers at the University of Virginia School of Medicine have identified an unexpected contributor to rheumatoid
ACR releases five 'Don'ts' for rheumatologists

ACR releases five 'Don'ts' for rheumatologists

As part of theChoosing Wiselycampaign, the American College of Rheumatology has issued a list of the top five tests and treatments commonly misordered by rheumatologists; the list has been

ACR releases five 'Don'ts' for rheumatologists

As part of theChoosing Wiselycampaign, the American College of Rheumatology has issued a list of the top five tests and treatments commonly misordered by rheumatologists; the list has been
Compound found to trigger innate immunity against viruses

Compound found to trigger innate immunity against viruses

by Bobbi Nodell,University of WashingtonCells under a microscope in a UW Medicine immunity lab. Credit: Dennis WiseResearch from UW Medicine and collaborators indicates that a drug-like molecule

Compound found to trigger innate immunity against viruses

by Bobbi Nodell,University of WashingtonCells under a microscope in a UW Medicine immunity lab. Credit: Dennis WiseResearch from UW Medicine and collaborators indicates that a drug-like molecule
Is it brain infection or cancer? A new rapid test could hold the answer

Is it brain infection or cancer? A new rapid test could hold the answer

by Thomas Jefferson UniversityGram stain of meningococci from a culture showing Gram negative (pink) bacteria, often in pairs. Credit: public domainWhen patients present with neurologic symptoms

Is it brain infection or cancer? A new rapid test could hold the answer

by Thomas Jefferson UniversityGram stain of meningococci from a culture showing Gram negative (pink) bacteria, often in pairs. Credit: public domainWhen patients present with neurologic symptoms
First-in-human trial with CAR macrophages shows promise targeting solid tumors

First-in-human trial with CAR macrophages shows promise targeting solid tumors

by Caren Begun,University of PennsylvaniaCredit: Pixabay/CC0 Public DomainPreliminary findings from Penn Medicine in an ongoing first-in-human clinical trial examining the safety, tolerability a

First-in-human trial with CAR macrophages shows promise targeting solid tumors

by Caren Begun,University of PennsylvaniaCredit: Pixabay/CC0 Public DomainPreliminary findings from Penn Medicine in an ongoing first-in-human clinical trial examining the safety, tolerability a
Recognizing young people's perspectives in inflammatory arthritis

Recognizing young people's perspectives in inflammatory arthritis

by EULARFigure 1 Example outlining the different steps of the analysis from a meaning unit to lower and higher level concepts. PROMs, patient-reported outcome measures.Inflammatory arthritis is the na

Recognizing young people's perspectives in inflammatory arthritis

by EULARFigure 1 Example outlining the different steps of the analysis from a meaning unit to lower and higher level concepts. PROMs, patient-reported outcome measures.Inflammatory arthritis is the na
Respiratory disease may increase risk for rheumatoid arthritis

Respiratory disease may increase risk for rheumatoid arthritis

(HealthDay)—Respiratory diseases increase the risk for rheumatoid arthritis, according to a study published online Aug. 16 inArthritis & Rheumatology.Vanessa L. Kronzer, M.D., from the Mayo

Respiratory disease may increase risk for rheumatoid arthritis

(HealthDay)—Respiratory diseases increase the risk for rheumatoid arthritis, according to a study published online Aug. 16 inArthritis & Rheumatology.Vanessa L. Kronzer, M.D., from the Mayo
Rituximab retreatment at clinical relapse cost-effective in RA

Rituximab retreatment at clinical relapse cost-effective in RA

(HealthDay)—Rituximab retreatment at clinical relapse is at least as cost-effective as a more intensive regimen in longstanding rheumatoid arthritis (RA), according to a study published in the July is

Rituximab retreatment at clinical relapse cost-effective in RA

(HealthDay)—Rituximab retreatment at clinical relapse is at least as cost-effective as a more intensive regimen in longstanding rheumatoid arthritis (RA), according to a study published in the July is
Researchers identify new target for rheumatoid arthritis

Researchers identify new target for rheumatoid arthritis

by Hospital for Special SurgeryCo-senior author and Program Director Carl Blobel, M.D., Ph.D., works with collaborator Lionel Ivashkiv, M.D., in the Arthritis and Tissue Degeneration Program lab

Researchers identify new target for rheumatoid arthritis

by Hospital for Special SurgeryCo-senior author and Program Director Carl Blobel, M.D., Ph.D., works with collaborator Lionel Ivashkiv, M.D., in the Arthritis and Tissue Degeneration Program lab
COVID-19 virus helps block host immunity

COVID-19 virus helps block host immunity

by Mary Ann Liebert, IncSARS-CoV-2 (shown here in an electron microscopy image). Credit: National Institute of Allergy and Infectious Diseases, NIHSARS-CoV-2, the virus that causes COVID-19, bloc

COVID-19 virus helps block host immunity

by Mary Ann Liebert, IncSARS-CoV-2 (shown here in an electron microscopy image). Credit: National Institute of Allergy and Infectious Diseases, NIHSARS-CoV-2, the virus that causes COVID-19, bloc